News | January 18, 2024
NATCO invests US$ 2 million in Cellogen Therapeutics
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
The workshop was conducted as a part of the NITI–State workshop series
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Leading USA based genetic testing brand officially enters the Indian market
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Subscribe To Our Newsletter & Stay Updated
